000			01754nam a2200409 i 4500
999			_c261491 _d261491
001			ocn995853747
003			BD
005			20180217134026.0
006			m o d f
007			cr bn||||m||||
008			170731s2017 dcu ob f000 0 eng c
040			_aPUCPR _beng _erda _epn _cGPO _dMvI
042			_apcc
043			_an-us---
049			_aBDDF
050	1	4	_aKF26 _b.F5 2016
074			_a1038-B (MF)
086	0		_aY 4.F 49:S.HRG.114-666
099			_aY 4.F 49:S.HRG.114-666
110	1		_aUnited States. _bCongress. _bSenate. _bCommittee on Finance, _eauthor.
245	1	0	_aExamining the proposed Medicare part B drug demonstration : _bhearing before the Committee on Finance, United States Senate, One Hundred Fourteenth Congress, second session, June 28, 2016.
264		1	_aWashington : _bU.S. Government Publishing Office, _c2017.
336			_atext _btxt _2rdacontent
337			_amicroform _bh _2rdamedia
338			_amicrofiche _bhe _2rdacarrier
490	1		_aS. hrg. ; _v114-666
500			_aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
500			_aCRDP Program record.
504			_aIncludes bibliographical references.
588			_aDescription based on online resource, PDF version; title from title page (FDsys web site, viewed on July 31, 2017).
650		0	_aMedicare.
650		0	_aDrugs _xPrices _xGovernment policy _zUnited States.
650		0	_aPharmaceutical services insurance _zUnited States.
655		7	_aLegislative hearings. _2lcgft
810	1		_aUnited States. _bCongress. _bSenate. _tS. hrg. ; _v114-666.
856	4	0	_3PDF version: _uhttp://purl.fdlp.gov/GPO/gpo83288
856	4	0	_3Text version: _uhttp://purl.fdlp.gov/GPO/gpo83289
942			_2sudocs _c12